What Filana Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 6 |
| Sells | 0 | 0 |
| Total trades | 3 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 399,904 | 631,889 |
| Disposed | 0 | 0 |
| Net activity | +399,904 | +631,889 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Barry Richard | President & CEO | Sep 30 | Open-market buy · P | +100,000 | $0.92 | +$92K | 1,337,964 |
| Barry Richard | President & CEO | Sep 29 | Open-market buy · P | +206,813 | $0.90 | +$186K | 1,237,964 |
| Barry Richard | President & CEO | Sep 28 | Open-market buy · P | +93,091 | $0.84 | +$78.2K | 1,031,151 |
| Anderson Robert Eugene Jr | Director | Nov 24 | Open-market buy · P | +8,600 | $2.90 | +$24.9K | 8,600 |
| Barry Richard | President & CEO | Nov 20 | Open-market buy · P | +150,000 | $2.76 | +$414K | 938,060 |
| Barry Richard | President & CEO | Nov 19 | Open-market buy · P | +73,385 | $2.75 | +$202K | 788,060 |
| Cook Robert Christopher | Chief Operating & Legal Office | Sep 30 | Open-market buy · P | +13,725 | $2.91 | +$39.9K | 13,725 |
| Barry Richard | President & CEO | Sep 22 | Open-market buy · P | +7,172 | $2.28 | +$16.4K | 714,675 |
| Barry Richard | President & CEO | Sep 19 | Open-market buy · P | +46,908 | $2.29 | +$107K | 707,503 |
| Barry Richard | President & CEO | Sep 19 | Open-market buy · P | +400 | $2.25 | +$900 | 660,595 |
| Barry Richard | President & CEO | Sep 18 | Open-market buy · P | +185,233 | $2.24 | +$415K | 660,195 |
| Barry Richard | President & CEO | Sep 18 | Open-market buy · P | +5,400 | $2.13 | +$11.5K | 474,962 |
| Kupiec James William | Chief Medical Officer | Nov 29 | Open-market sale · S | −4,000 | $3.87 | −$15.5K | 0 |
| Schoen Eric | Chief Financial Officer | Nov 29 | Open-market sale · S | −59,800 | $3.86 | −$231K | 11,500 |
| Schoen Eric | Chief Financial Officer | Nov 29 | Open-market sale · S | −2,000 | $3.82 | −$7.64K | 0 |
| Schoen Eric | Chief Financial Officer | Nov 29 | Exercise / conversion · M | +50,000 | $1.18 | +$59K | 71,300 |
| Robertson Sanford | Director | May 16 | Gift · G | +5,000 | — | — | 5,000 |
| Robertson Sanford | Director | May 16 | Gift · G | −5,000 | — | — | 950,851 |
| Robertson Sanford | Director | Apr 26 | Exercise / conversion · M | +69,000 | $22.00 | +$1.52M | 955,851 |
| Barry Richard | Director | Apr 23 | Exercise / conversion · M | +176,085 | $22.00 | +$3.87M | 469,562 |
Loading...
